Clinics and Practice,
Journal Year:
2025,
Volume and Issue:
15(3), P. 47 - 47
Published: Feb. 25, 2025
Background:
Traumatic
brain
injury
(TBI)
is
often
associated
with
other
injuries
and
comorbidities.
However,
even
isolated
TBI
directly
leads
to
dysfunction
in
multiple
body
systems
outside
the
central
nervous
system.
These
extracranial
effects
of
target
including
autonomic
nervous,
cardiovascular,
renal,
pulmonary,
immune,
gastrointestinal,
hemostasis
systems,
as
well
causing
significant
alteration
systemic
metabolism.
Aim:
This
review
intended
outline
on
place
these
context
treatment
considerations
for
patients.
Significance:
Systemic
have
implications
acute
critical
care
management
patients
TBI,
pharmacologic
treatment.
They
also
affect
decisions
chronic
care,
TBI-unrelated
routine
medical
TBI.
In
addition,
should
be
considered
research
settings.
Conclusions:
It
important
clinicians
researchers
aware
effects,
consider
their
pathology,
decisions,
interpretation
findings.
Journal of Clinical Investigation,
Journal Year:
2021,
Volume and Issue:
131(12)
Published: June 14, 2021
Traumatic
brain
injury
(TBI)
is
a
chronic
and
progressive
disease,
management
requires
an
understanding
of
both
the
primary
neurological
secondary
sequelae
that
affect
peripheral
organs,
including
gastrointestinal
(GI)
tract.
The
brain-gut
axis
composed
bidirectional
pathways
through
which
TBI-induced
neuroinflammation
neurodegeneration
impact
gut
function.
resulting
dysautonomia
systemic
inflammation
contribute
to
GI
events,
dysmotility
increased
mucosal
permeability.
These
effects
shape,
are
shaped
by,
changes
in
microbiota
composition
activation
resident
recruited
immune
cells.
Microbial
products
cell
mediators
turn
modulate
activity.
Importantly,
enteric
inflammatory
challenges
prolong
worsen
neuropathology
neurobehavioral
deficits.
importance
communication
maintaining
homeostasis
highlights
it
as
viable
therapeutic
target
for
TBI.
Currently,
treatments
directed
toward
dysautonomia,
dysbiosis,
and/or
offer
most
promise.
Critical Care,
Journal Year:
2021,
Volume and Issue:
25(1)
Published: Oct. 13, 2021
Abstract
During
the
last
decade,
experimental
and
clinical
studies
have
demonstrated
that
isolated
acute
brain
injury
(ABI)
may
cause
severe
dysfunction
of
peripheral
extracranial
organs
systems.
Of
all
potential
target
systems,
lung
appears
to
be
most
vulnerable
damage
after
(BI).
The
pathophysiology
these
brain–lung
interactions
are
complex
involve
neurogenic
pulmonary
oedema,
inflammation,
neurodegeneration,
neurotransmitters,
immune
suppression
autonomic
system.
systemic
effects
inflammatory
mediators
in
patients
with
BI
create
a
environment
makes
secondary
procedures
enhance
such
as
mechanical
ventilation
(MV),
surgery
infections.
Indeed,
previous
shown
presence
environment,
specific
neurointensive
care
interventions—such
MV—may
significantly
contribute
development
injury,
regardless
underlying
mechanisms.
Although
current
knowledge
supports
protective
BI,
it
must
born
mind
ABI-related
has
distinct
mechanisms
between
lungs.
In
this
context,
role
extracerebral
pathophysiology,
especially
lungs,
often
been
overlooked,
physicians
focus
on
intracranial
cerebral
dysfunction.
present
review
aims
fill
gap
by
describing
complications
due
injuries
single
ABI,
discusses
possible
impact
MV
neurocritical
normal
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(26)
Published: June 20, 2023
Traumatic
brain
injury
(TBI)
is
a
pervasive
problem
worldwide
for
which
no
effective
treatment
currently
available.
Although
most
studies
have
focused
on
the
pathology
of
injured
brain,
we
noted
that
liver
plays
an
important
role
in
TBI.
Using
two
mouse
models
TBI,
found
enzymatic
activity
hepatic
soluble
epoxide
hydrolase
(sEH)
was
rapidly
decreased
and
then
returned
to
normal
levels
following
whereas
such
changes
were
not
observed
kidney,
heart,
spleen,
or
lung.
Interestingly,
genetic
downregulation
Ephx2
(which
encodes
sEH)
ameliorates
TBI-induced
neurological
deficits
promotes
function
recovery,
overexpression
sEH
exacerbates
TBI-associated
impairments.
Furthermore,
ablation
promote
generation
A2
phenotype
astrocytes
facilitate
production
various
neuroprotective
factors
associated
with
We
also
inverted
V-shaped
alteration
plasma
four
EET
(epoxyeicosatrienoic
acid)
isoforms
(5,6-,
8,9-,11,12-,
14,15-EET)
TBI
negatively
correlated
activity.
However,
manipulation
bidirectionally
regulates
14,15-EET,
crosses
blood–brain
barrier.
Additionally,
application
14,15-EET
mimicked
effect
ablation,
while
14,15-epoxyeicosa-5(Z)-enoic
acid
blocked
this
effect,
indicating
increased
mediated
after
ablation.
These
results
highlight
suggest
targeting
signaling
could
represent
promising
therapeutic
strategy
treating
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: May 10, 2024
Abstract
Traumatic
brain
injury
(TBI)
is
a
chronic
and
debilitating
disease,
associated
with
high
risk
of
psychiatric
neurodegenerative
diseases.
Despite
significant
advancements
in
improving
outcomes,
the
lack
effective
treatments
underscore
urgent
need
for
innovative
therapeutic
strategies.
The
brain-gut
axis
has
emerged
as
crucial
bidirectional
pathway
connecting
gastrointestinal
(GI)
system
through
an
intricate
network
neuronal,
hormonal,
immunological
pathways.
Four
main
pathways
are
primarily
implicated
this
crosstalk,
including
systemic
immune
system,
autonomic
enteric
nervous
systems,
neuroendocrine
microbiome.
TBI
induces
profound
changes
gut,
initiating
unrestrained
vicious
cycle
that
exacerbates
axis.
Alterations
gut
include
mucosal
damage
malabsorption
nutrients/electrolytes,
disintegration
intestinal
barrier,
increased
infiltration
cells,
dysmotility,
dysbiosis,
enteroendocrine
cell
(EEC)
dysfunction
disruption
(ENS)
(ANS).
Collectively,
these
further
contribute
to
neuroinflammation
neurodegeneration
via
gut-brain
In
review
article,
we
elucidate
roles
various
anti-inflammatory
pharmacotherapies
capable
attenuating
dysregulated
inflammatory
response
along
TBI.
These
agents
hormones
such
serotonin,
ghrelin,
progesterone,
ANS
regulators
beta-blockers,
lipid-lowering
drugs
like
statins,
flora
modulators
probiotics
antibiotics.
They
attenuate
by
targeting
distinct
both
post-TBI.
exhibit
promising
potential
mitigating
inflammation
enhancing
neurocognitive
outcomes
patients.
Critical Care,
Journal Year:
2024,
Volume and Issue:
28(1)
Published: March 7, 2024
Abstract
It
has
been
convincingly
demonstrated
in
recent
years
that
isolated
acute
brain
injury
(ABI)
may
cause
severe
dysfunction
of
peripheral
extracranial
organs
and
systems.
Of
all
potential
target
systems,
the
lung
appears
to
be
most
vulnerable
damage
after
ABI.
The
pathophysiology
bidirectional
brain–lung
interactions
is
multifactorial
involves
inflammatory
cascades,
immune
suppression,
autonomic
system.
Indeed,
systemic
effects
mediators
patients
with
ABI
create
a
environment
(“first
hit”)
makes
secondary
procedures
enhance
inflammation,
such
as
mechanical
ventilation
(MV),
surgery,
infections
(“second
hit”).
Moreover,
accumulating
evidence
supports
knowledge
gut
microbiota
constitutes
critical
superorganism
an
organ
on
its
own,
potentially
modifying
various
physiological
functions
host.
Furthermore,
experimental
clinical
data
suggest
existence
communication
network
among
brain,
gastrointestinal
tract,
microbiome,
which
regulate
responses,
function,
behavior,
stress
also
named
“gut-microbiome–brain
axis.”
Additionally,
research
highlighted
crucial
interplay
between
intestinal
lungs,
referred
“gut-lung
axis,”
alterations
during
illness
could
result
bacterial
translocation,
sustained
injury,
pulmonary
fibrosis.
In
present
work,
we
aimed
further
elucidate
(ALI)
by
attempting
develop
“double-hit”
theory,
proposing
“triple-hit”
hypothesis,
focused
influence
gut–lung
axis
lung.
Particularly,
propose,
addition
sympathetic
hyperactivity,
blast
double-hit
dysbiosis
context
alter
axis,
resulting
development
or
aggravation
existing
ALI,
“third
hit.”
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(14), P. 4946 - 4946
Published: July 13, 2020
As
brain
and
bone
disorders
represent
major
health
issues
worldwide,
substantial
clinical
investigations
demonstrated
a
bidirectional
crosstalk
on
several
levels,
mechanistically
linking
both
apparently
unrelated
organs.
While
multiple
stress,
mood
neurodegenerative
are
associated
with
osteoporosis,
rare
genetic
skeletal
diseases
display
impaired
development
function.
Along
pathologies,
particularly
trauma
events
highlight
the
strong
interaction
of
This
review
summarizes
experimental
observations
reported
for
bone,
followed
by
detailed
overview
their
molecular
bases.
brain-derived
molecules
affecting
include
central
regulators,
transmitters
sympathetic,
parasympathetic
sensory
nervous
system,
bone-derived
mediators
altering
function
released
from
cells
marrow.
Although
main
pathways
brain-bone
remain
‘efferent’,
signaling
to
this
emphasizes
emergence
as
crucial
‘afferent’
regulator
cerebral
development,
pathophysiology.
Therefore,
unraveling
physiological
pathological
bases
interactions
revealed
promising
pharmacologic
targets
novel
treatment
strategies
promoting
concurrent
recovery.
Advanced Functional Materials,
Journal Year:
2021,
Volume and Issue:
31(30)
Published: March 26, 2021
Traumatic
brain
injury
(TBI)
triggers
both
central
and
peripheral
inflammatory
responses.
Existing
pharmacological
drugs
are
unable
to
effectively
quickly
target
the
inflamed
regions,
setting
up
a
major
roadblock
towards
effective
trauma
treatments.
Nanoparticles
(NPs)
have
been
used
in
multiple
diseases
as
drug
delivery
tools
with
remarkable
success
due
their
rapid
diffusion
specificity
organ.
Here,
leukocyte-based
biomimetic
NPs
fabricated
theranostic
tool
directly
access
regions
TBI
mouse
model.
This
NP
systemic
is
visualized
using
advanced
vivo
imaging
techniques,
including
intravital
microscopy
system.
The
results
demonstrate
selective
targeting
of
injured
increased
accumulation
among
organs
24
h
after
TBI.
Interestingly,
microglial
proliferation,
decreased
macrophage
infiltration,
reduced
lesion
following
treatments
compared
sham
vehicle-treated
mice
also
found.
In
summary,
suggest
that
represent
promising
future
for
treatment.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: Feb. 15, 2021
Mild
traumatic
brain
injury
(mild
TBI),
often
referred
to
as
concussion,
is
the
most
common
form
of
TBI
and
affects
millions
people
each
year.
A
history
mild
increases
risk
developing
emotional
neurocognitive
disorders
later
in
life
that
can
impact
on
day
living.
These
include
anxiety
depression,
well
neurodegenerative
conditions
such
chronic
encephalopathy
(CTE)
Alzheimer's
disease
(AD).
Actions
resident
or
peripherally
recruited
immune
cells
are
proposed
be
key
regulators
across
these
diseases
mood
disorders.
Here,
we
will
assess
patient
health,
evaluate
recent
evidence
for
cell
involvement
its
pathogenesis.